Abstract

Color Additives: Legislative Perspective in the United States, Europe, Australia, and India

Author(s): Kumar Anuj, Madan Anil K

Issue: Jul/Aug 2014 - Volume 18, Number 4

Page(s): 293-300

Download in electronic PDF format for $75
  • Color Additives: Legislative Perspective in the United States, Europe, Australia, and India Page 1
  • Color Additives: Legislative Perspective in the United States, Europe, Australia, and India Page 2
  • Color Additives: Legislative Perspective in the United States, Europe, Australia, and India Page 3
  • Color Additives: Legislative Perspective in the United States, Europe, Australia, and India Page 4
  • Color Additives: Legislative Perspective in the United States, Europe, Australia, and India Page 5
  • Color Additives: Legislative Perspective in the United States, Europe, Australia, and India Page 6
  • Color Additives: Legislative Perspective in the United States, Europe, Australia, and India Page 7
  • Color Additives: Legislative Perspective in the United States, Europe, Australia, and India Page 8

Abstract

In most countries, their regulatory bodies which control food, drugs, and cosmetics are responsible for regulating all the color additives to ensure that they are safe with those products, ensuring that they contain only approved ingredients, and that they are accurately labeled. Permitted colors are subject to rigorous safety standards prior to their approval and prior to the release of their specific use. Although a colorant may have approval in several countries, its use, level of use, specifications, acceptance criteria, and labeling requirements may differ from one country to another. In this review, we have explored the legislative and regulatory framework regarding the color additives for use in drugs and cosmetics.

Related Keywords

  • color additives
  • pharmacy regulation
  • drug safety
  • colorant
  • United States
  • patient acceptance
  • patient adherence
  • patient compliance
  • legislation
  • dye
  • pigment
  • certification
  • Europe
  • purity criteria
  • European Union
  • Australia
  • India

Related Categories

  • EXCIPIENTS
  • LEGAL

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2014
Pg. 293-300
Color Additives: Legislative Perspective in the United States, Europe, Australia, and India
Author(s): Kumar Anuj, Madan Anil K
Jul/Aug 2012
Pg. 304-309
Selection of Color Additives: A Regulatory View
Author(s): Kumar Anuj, Dureja Harish, Madan Anil K
Mar/Apr 2021
Pg. 115-124
Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice
Author(s): Kelley Brian
May/Jun 2020
Pg. 180
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>, <797>, and <825>: Part 2
Author(s): Allen Loyd V Jr
Mar/Apr 2020
Pg. 92
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1
Author(s): Allen Loyd V Jr
Jan/Feb 2013
Pg. 48-49
International Academy of Compounding Pharmacists' Recommendations for State-based Legislative and Regulatory Initiatives
Author(s): Miller David G
Sep/Oct 2018
Pg. 401-404
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1
Author(s): Martin Matt
Mar/Apr 2021
Pg. 92
PreScription: The Past (-->2020), The Present, and The Future (2021-->)
Author(s): Allen Loyd V Jr
May/Jun 2009
Pg. 224-229
Compounded Medications in a Hospital Setting: Patient Counseling and Staff Education
Author(s): McElhiney Linda F
Jul/Aug 2013
Pg. 283-288
United States Pharmacopeia Chapter <797> Timeline: 1989 to 2013
Author(s): Newton David W
Mar/Apr 2019
Pg. 120-121
Patient Access Is a Patient Safety Issue
Author(s): Pore David
Mar/Apr 1997
Pg. 84-86
Compounding for the Pediatric Patient
Author(s): Allen Loyd V Jr
Jul/Aug 2003
Pg. 258-263
Patient Satisfaction with Pharmacist Intervention and Consultation in HRT
Author(s): DiMaggio Jennifer Lyn, Reed-Kane Dana
Mar/Apr 2002
Pg. 123
Medications Discontinued in the United States
Author(s): Ashworth Lisa D
Jul/Aug 2010
Pg. 328-331
Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program
Author(s): Okeke Claudia C, Allen Loyd V Jr
Mar/Apr 2012
Pg. 146-150
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 1
Author(s): Allen Loyd V Jr
Jul/Aug 2014
Pg. 318-319
Basics of Compounding: Tips and Hints, Part 4: Lollipops/Lozenges, Gummy Bears, Patches, Flavoring/Coloring, Sweeteners, and Packaging
Author(s): Allen Loyd V Jr
Nov/Dec 2015
Pg. 453-463
Applying Quality of Design Concepts to Pharmacy Compounding
Author(s): Timko Robert J
Sep/Oct 2020
Pg. 371-379
Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance
Author(s): Greeson Nicole MH, Mixon William, Allan W Chris
May/Jun 2017
Pg. 180
PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives
Author(s): Allen Loyd V Jr